Conclusion
Quality risk management applied to pharmaceutical product development
Article REF: PHA3051 V1
Conclusion
Quality risk management applied to pharmaceutical product development

Authors : Jean-Jacques HOURI, Mélisande BERNARD, Hassane SADOU-YAYE, Bernard DO

Publication date: February 10, 2016 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

8. Conclusion

The example presented in this article is in the spirit of the new approach to quality, as defined in the ICH Q8 to ICH Q10 recommendations. Implementing quality by design requires manufacturers to understand the product from conception to marketing, through a deeper understanding of the product and the manufacturing process. The advantages generated by this new approach are undeniably the reduction of the risk of generating a non-compliant product, and the assurance of better quality risk management.

Among the fundamental points of the example we have chosen, we have noted that defining the particle size distribution of the active substance makes it possible to control the impact of this parameter on the initial mixing of the powders, to guarantee the homogeneity of the distribution of the active substance and the expected dissolution characteristics in vitro, and...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Article included in this offer

"Drugs and pharmaceuticals"

( 125 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details
Contact us